EUVIMEDOpdag EUVIMED
Crossref

Arbidol, an antiviral drug, identified as a sodium channel blocker with anticonvulsant activity

Min Li, Yuchen Jin, Jun Wu, Miao Zhao, Kexin Yu, Haibo Yu iD

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.16496 ↗

At a glance

Journal article in British Journal of Pharmacology, 2024. Written by Min Li and 5 co-authors. Institution: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and P…. Major MEDLINE topics: Anticonvulsants, Antiviral Agents, Seizures, Indoles. 51 references. Funded by: CAMS Innovation Fund for Medical Sciences, National Natural Science Foundation of China, Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and purpose Sodium channel blockers (SCBs) have traditionally been utilized as anti‐seizure medications by primarily targeting the inactivation process. In a drug discovery project aiming at finding potential anticonvulsants, we have identified arbidol, originally an antiviral drug, as a potent SCB. In order to evaluate its anticonvulsant potential, we have thoroughly examined its biophysical properties as well as its effects on animal seizure models. Experimental approach Patch clamp recording was used to investigate the electrophysiological properties of arbidol, as well as the binding and unbinding kinetics of arbidol, carbamazepine and lacosamide. Furthermore, we evaluated the anticonvulsant effects of arbidol using three different seizure models in male mice. Key results Arbidol effectively suppressed neuronal epileptiform activity by blocking sodium channels. Arbidol demonstrated a distinct mode of action by interacting with both the fast and slow inactivation of Na v 1.2 channels compared with carbamazepine and lacosamide. A kinetic study suggested that the binding and unbinding rates might be associated with the specific characteristics of these three drugs. Arbidol targeted the classical binding site of local anaesthetics, effectively inhibited the gain‐of‐function effects of Na v 1.2 epileptic mutations and exhibited varying degrees of anticonvulsant effects in the maximal electroshock model and subcutaneous pentylenetetrazol model but had no effect in the pilocarpine‐induced status epilepticus model. Conclusions and implications Arbidol shows promising potential as an anticonvulsant agent, providing a unique mode of action that sets it apart from existing SCBs.

Subjects

MeSH terms (MEDLINE)

AnticonvulsantsAntiviral AgentsSeizuresIndolesSodium Channel BlockersAnimalsMaleMiceLacosamideHumansAcetamidesNAV1.2 Voltage-Gated Sodium ChannelHEK293 CellsCarbamazepineSulfides

Author keywords

anti‐seizure medicinesarbidolcarbamazepinelacosamidesodium channel blockers

Substances

AnticonvulsantsAntiviral AgentsIndolesumifenovirSodium Channel BlockersLacosamideAcetamidesNAV1.2 Voltage-Gated Sodium ChannelCarbamazepineSulfides

Authors and institutions

  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.

ORCID profiles: Haibo Yu

Funding

  • CAMS Innovation Fund for Medical Sciences
  • National Natural Science Foundation of China
  • Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study

Cite

APA

Li, M., Jin, Y., Wu, J., Zhao, M., Yu, K., & Yu, H. (2024). Arbidol, an antiviral drug, identified as a sodium channel blocker with anticonvulsant activity. British Journal of Pharmacology. https://doi.org/10.1111/bph.16496

Vancouver

Li M, Jin Y, Wu J, Zhao M, Yu K, Yu H. Arbidol, an antiviral drug, identified as a sodium channel blocker with anticonvulsant activity. British Journal of Pharmacology. 2024. doi:10.1111/bph.16496

BibTeX
@article{Li2024,
  author = {Li, Min and Jin, Yuchen and Wu, Jun and Zhao, Miao and Yu, Kexin and Yu, Haibo},
  title = {Arbidol, an antiviral drug, identified as a sodium channel blocker with anticonvulsant activity},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.16496}
}
Start for free →